Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
Clinical trial NCT06079190 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06079190
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-20
- Primary completion
- 2026-09-30
- Enrollment
- 367
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.